CERT
Certara accelerates drug development with proprietary biosimulation software, technology, and services that integrate data-driven modeling and predictive simulation. The company supports the entire development journey—from discovery through late-stage clinicals and market access—using model-informed strategies and AI-guided insights. It serves biopharmaceutical companies, academia, and regulatory agencies across 62 countries. With solutions spanning regulatory science, discovery, preclinical, and clinical optimization, Certara helps make drug development faster, safer, and more cost-efficient.
No recent deals for this company.